COVID-19 patients on an antidepressant were less likely to die from the infection, a retrospective study found. Compared with patients not on an antidepressant, patients with COVID-19 who were taking ...
Nov. 15 (UPI) --Treating COVID-19 patients with antidepressant drugs called selective serotonin reuptake inhibitors, or SSRIs, appears to reduce disease severity, a study published Monday by JAMA ...
LONDON, Feb. 26 -- Five antidepressants given for obsessive compulsive disorder all seem to confer twice the likelihood of modest symptom relief compared with placebo, found a systematic Cochrane ...
Evidence shows weak antiviral activity and no improvement in symptom outcomes. Study: Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive ...
March 22, 2004 — The U.S. Food and Drug Administration (FDA) has asked manufacturers of the several antidepressant drugs to include in their labeling a warning statement that recommends close ...
Recently, an antidepressant called fluvoxamine (Luvox) has made headlines as a possible low-cost treatment for Covid. How does that work? Fluvoxamine belongs to a common class of antidepressants ...
A comprehensive meta-analysis of 12 new-generation antidepressants has shown sertraline and escitalopram have clear advantages in terms of efficacy and acceptability, while reboxetine was shown to be ...
August 12, 2010 — Based on the research to date, selective serotonin reuptake inhibitors (SSRIs) cannot be recommended for treating autism in children or adults, the results of a new Cochrane review ...
Autism is a developmental disorder of unknown etiology that has a major impact on individuals with the disorder, their families, and society. While there is a great need to find medications that can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback